37038 Federal Register / Vol. 74, No. 142 / Monday, July 27, 2009 / Notices 

child, information describing the type of 

trafficking and circumstances 

surrounding the situation, and the 

strengths and needs of the child. The 

form also asks the requestor to verify the 

information contained in the form 

because the information could be the 

basis for a determination of an alien 

child’s eligibility for federally funded 

benefits. Finally, the form takes into 

consideration the need to compile 

information regarding a child’s 

circumstances and experiences in a nondirective, child-friendly way, and assists 

the potential requestor in assessing 

whether the child may have been 

subjected to trafficking in persons. 

The information provided through the 

completion of a Request for Assistance 

for Child Victims of Human Trafficking 

form will enable HHS to make prompt 

determinations regarding the eligibility 

of an alien child for interim assistance, 

inform HHS’ determination regarding 

the child’s eligibility for assistance as a 

victim of a severe form of trafficking in 

persons, facilitate the required 

consultation process, and enable HHS to 

assess and address potential child 

protection issues. 

Respondents: Representatives of 

governmental and nongovernmental 

entities providing social, legal, or 

protective services to non-U.S. citizen 

(alien) individuals under the age of 18 

(children) in the United States who may 

have been subjected to severe forms of 

trafficking in persons. 

ANNUAL BURDEN ESTIMATES

Instrument Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden hours 

per response 

Total burden 

hours 

Request for Assistance for Child Victims of Human Trafficking ..................... 50 1 1 50 

Estimated Total Annual Burden 

Hours: 50 

Additional Information: Copies of the 

proposed collection may be obtained by 

writing to the Administration for 

Children and Families, Office of 

Administration, Office of Information 

Services, 370 L’Enfant Promenade, SW., 

Washington, DC 20447, Attn: ACF 

Reports Clearance Officer. All requests 

should be identified by the title of the 

information collection. E-mail address: 

infocollection@acf.hhs.gov. 

OMB Comment: OMB is required to 

make a decision concerning the 

collection of information between 30 

and 60 days after publication of this 

document in the Federal Register. 

Therefore, a comment is best assured of 

having its full effect if OMB receives it 

within 30 days of publication. Written 

comments and recommendations for the 

proposed information collection should 

be sent directly to the following: Office 

of Management and Budget, Paperwork 

Reduction Project, Fax: 202–395–7245, 

Attn: Desk Officer for the 

Administration for Children and 

Families. 

Dated: July 22, 2009. 

Janean Chambers, 

Reports Clearance Officer. 

[FR Doc. E9–17816 Filed 7–24–09; 8:45 am] 

BILLING CODE 4184–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–09–0469] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

In compliance with the requirement 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. To 

request more information on the 

proposed projects or to obtain a copy of 

the data collection plans and 

instruments, call 404–639–5960 or send 

comments to Maryam I. Daneshvar, CDC 

Acting Reports Clearance Officer, 1600 

Clifton Road, MS D–74, Atlanta, GA 

30333 or send an email to omb@cdc.gov. 

Comments are invited on: (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Written comments should 

be received within 60 days of this 

notice. 

Proposed Project 

National Program of Cancer Registries 

Cancer Surveillance System— 

Revision—National Center for Chronic 

Disease Prevention and Health 

Promotion (NCCDPHP), Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

Cancer is the second leading cause of 

death in the United States, second only 

to heart disease. In 2005, the most 

recent year for which complete 

information is available, more than 

500,000 people died of cancer and more 

than 1.34 million were diagnosed with 

cancer. In addition to the personal 

impact of cancer, the financial burden is 

also substantial. The direct treatment 

costs of cancer in 2008 have been 

estimated at $93.2 billion, with 

additional indirect costs of $134.9 

billion in lost productivity due to illness 

and premature death. 

In 1992, Congress passed the Cancer 

Registries Amendment Act which 

established the National Program of 

Cancer Registries (NPCR). The NPCR 

provides support for central cancer 

registries (CCR) that collect, manage and 

analyze data about cancer cases. The 

NPCR-funded CCRs, which are located 

in states, the District of Columbia, and 

U.S. territories, report information to 

CDC annually through the National 

Program of Cancer Registries Cancer 

Surveillance System (NPCR CSS) (OMB 

No. 0920–0469, exp. 1/31/2010). CDC 

plans to request OMB approval to 

continue collecting this information for 

three years. 

The NPCR CSS allows CDC to collect, 

aggregate, evaluate and disseminate 

cancer incidence data at the national 

level. The NPCR CSS is the primary 

source of information for United States 


jlentini on DSKJ8SOYB1PROD with NOTICES
Federal Register / Vol. 74, No. 142 / Monday, July 27, 2009 / Notices 37039 

Cancer Statistics (USCS), which CDC 

has published annually since 2002. The 

latest USCS report published in 2009 

provided cancer statistics for 96% of the 

United States population from all cancer 

registries whose data met national data 

standards. Prior to the publication of 

USCS, cancer incidence data at the 

national level were available for only 

14% of the population of the United 

States. 

The NPCR CSS also allows CDC to 

monitor cancer trends over time, 

describe geographic variation in cancer 

incidence throughout the country, and 

provide incidence data on minority 

populations and rare cancers. These 

activities and analyses further support 

CDC’s planning and evaluation efforts 

for state and national cancer control and 

prevention. In addition, datasets can be 

made available for secondary analysis. 

Each responding CCR is asked to 

report a cumulative file containing 

incidence data from the first diagnosis 

year for which the cancer registry 

collected data with the assistance of 

NPCR funds (e.g., 1995) through 12 

months past the close of the most recent 

diagnosis year (e.g., 2007). Because 

cancer incidence data are already 

collected and aggregated at the state 

level the additional burden of reporting 

the information to CDC is small. 

Information is transmitted to CDC 

electronically once per year. 

The Revision request will include 

changes. First, data definitions will be 

updated to reflect changes in national 

standards for cancer diagnosis and 

coding. In addition, the number of 

respondents will decrease. Respondents 

will be 45 stated-based CCRs, the CCR 

of the District of Columbia, the CCR of 

Puerto Rico, and the CCR that aggregates 

information from 10 flag territories and 

freely associated states in the Pacific 

Islands. In the previous OMB approval 

period, the territories, commonwealths, 

or freely-associated states were counted 

as individual respondents. In the next 

OMB approval period, the 10 flag 

territories, commonwealths, and freelyassociated states will be counted as one 

respondent to more accurately reflect 

funding, operations and actual response 

burden. States that receive sole funding 

from the National Cancer Institute are 

not included as respondents. The 

adjusted number of respondents will 

result in a reduction in the total 

estimated burden hours for the NPCR 

CSS. The estimated burden per response 

will not change. 

There are no costs to respondents 

except their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Respondents Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden 

per response 

(in hours) 

Total burden 

(in hours) 

Central Cancer Registries in States, Territories, and the District of Columbia 48 1 2 96 

Dated: July 17, 2009. 

Maryam I. Daneshvar, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. E9–17781 Filed 7–24–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel, Clinical Trial Planning 

Grant. 

Date: August 13, 2009. 

Time: 12 p.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6700B 

Rockledge Drive, Bethesda, MD 20817 

(Telephone Conference Call). 

Contact Person: Kenneth E. Santora, PhD, 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

NIH/NIAID/DHHS, 6700B Rockledge Drive, 

MSC 7616, Bethesda, MD 20892–7616, 301– 

496–2550, ks216i@nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: July 21, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–17833 Filed 7–24–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Alcohol Abuse 

and Alcoholism; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Alcohol Abuse and Alcoholism Special 

Emphasis Panel; NIAAA–NOT–OD–09–058 

Competitive Revision Supplement. 

Date: July 29–August 3, 2009. 

Time: 9 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 


jlentini on DSKJ8SOYB1PROD with NOTICES